The non-receptor tyrosine kinase TNK2/ACK1 is a novel therapeutic target in triple negative breast cancer
Xinyan Wu(Shandong University of Technology), Akhilesh Pandey(Mayo Clinic), Edward Gabrielson(Johns Hopkins University), Mustafa A. Barbhuiya(Johns Hopkins Medicine), Pavani Malla(Moffitt Cancer Center), Dhanashree Kelkar(Institute of Bioinformatics), Pamela Leal Rojas(Johns Hopkins University), Santosh Renuse(AstraZeneca (United States)), Saraswati Sukumar(Johns Hopkins University), Nupam P. Mahajan(Washington University in St. Louis), Vered Stearns(Johns Hopkins University), Muhammad Saddiq Zahari(Johns Hopkins University)
Cited by 60
Related Papers
The Genomic Landscapes of Human Breast and Colorectal Cancers
|Science|2007|2.8k
A draft map of the human proteome
|Nature|2014|2.3k
Molecular Definition of Breast Tumor Heterogeneity
|Cancer Cell|2007|1.4k
CYP2D6 Genotype, Antidepressant Use, and Tamoxifen Metabolism During Adjuvant Breast Cancer Treatment
|JNCI Journal of the National Cancer Institute|2005|947